baber/WOPTO huggingface dataset:
Patent NZ-553567-A (NZ)
Title: Duplicate document detection and presentation functions
Inventor: CONRAD JACK G
IPC: G06F17/30
Filed: 2005-08-23
Abstract: An information-retrieval system comprises one or more databases; and one or more servers for facilitating client access to the databases over a network. Each server includes query-definition means for facilitating user submission of a query and user selection of an option related to identification of search-result documents that include content duplicative of one or more other search-result documents; duplicate-determination means for determining whether one or more of the search-result documents include content duplicative of content in one or more other search result documents and means for controlling display of search-result documents based on the selected option, with at least one of the displayed results indicated as including content duplicative of content in one or more other documents within the results. The duplicate-determination means can include means for comparing first and second hash values for the respective first and second documents, with each hash value based on features and positions of the features within its respective document; means for comparing a first document signature for a first one of the documents within the results to a second document signature for a second one of the documents within the results, with each signature based on a plurality of terms and their corresponding positions within its corresponding document; means for comparing a set of features common to the first and second documents, the set of features comprising features selected based on a corresponding inverse-document-frequency (idf) value with the first and second documents having at least a threshold number of features in common with each other; and means for comparing, respectively, first and second lengths and first and second temporal features of the first and second documents. The duplicate-determination means is adapted to determine whether the first and second documents are duplicates in response to the results of the comparing means. Each of the servers can further include a signature-generation means for generating a plurality of document signatures, with each document signature based on a plurality of features from and their respective positions in a corresponding document in one or more of the databases. The signature-generation means comprising means for forming a document signature based on one or more of the group consisting of document hash value and a document feature vector. The hash value is based on features and positions of the features within a document;
Patent NZ-565651-A (NZ)
Title: Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
Inventor: FORSGREN ARNE
IPC: A61P31/04
Filed: 2006-08-08
Abstract: Disclosed is peptide consisting of Sequence ID No. 2. Also disclosed is Peptide consisting of Sequence ID No. 3. Further disclosed is a medicament or vaccine comprising a ligand comprising a fibronectin binding domain, said ligand consisting of an amino acid sequence selected from the group consisting of Sequence ID No. 2 and Sequence ID No. 3.
Patent NZ-566780-A (NZ)
Title: Thermal energy system with solar collection and controller to predict operation and change flow rate
Inventor: VIRK GURVINDER SINGH
IPC: F24S10/70
Filed: 2006-06-29
Abstract: Disclosed is a thermal energy system (3) for heating and/or cooling applications. The system has: solar collection means (10) for transferring heat energy to and/or from a heat transfer fluid; thermal upgrading means (44) for increasing the thermal energy within the system; and thermal storage means (48, 50). The collection means, upgrading means and storage means are connected so as to allow the transfer of heat there between via the heat transfer fluid. Control means are arranged to receive readings of operational variables from the thermal energy system and to process the operational variables using a system model so as to predict future operational variables for the system. The control means controls the flow of the heat transfer fluid around the system based on the predicted operational variables. The flow is controlled by controlling of operation of one or more pumps (36, 62, 70, 78, 80) or fans and one or more valves (40, 42, 54, 86), the valves being disposed between the solar collection means and the thermal storage means.
Patent NZ-570215-A (NZ)
Title: Reclining chair with pre-recline position when pins in slot extend from a contact end to another contact end
Inventor: LAPOINTE LARRY P
IPC: A47C1/035
Filed: 2007-01-10
Abstract: Disclosed is a furniture member actuation mechanism (32). A release latch (31) is manually actuated which causes the actuation mechanism to reposition the leg rest (24) from a stowed position to an extended position by extension of linkage sets (34) connecting the leg rest to the actuation member. First and second leg rest support arms are each connected by the pantograph linkage sets to a drive rod disposed through the side plates. A rearward force applied by an occupant to the support elements rotates them rearward with the first and second pins sliding within the elongated slots. An occupant's weight when the rearward force is removed returns the support elements to a pre-rotation position.
Patent NZ-570816-A (NZ)
Title: 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chain
Inventor: DELUCA HECTOR F
IPC: A61P35/00
Filed: 2007-04-06
Abstract: Disclosed is a compound of the pictured formula, where the substituents are as defined in the specification. Also disclosed is the use of the compound for treating cancer, autoimmune diseases, inflammatory diseases, skin conditions, and renal osteodystrophy.
Patent NZ-574076-A (NZ)
Title: Transaction instruments with enhanced security pin and expiration date generation
Inventor: NEWBROUGH KEITH
IPC: H04K1/00
Filed: 2007-06-07
Abstract: A transaction instrument (10c, 10e) with enhanced expiration date generation and a method of providing enhanced security to financial transactions using the transaction instrument are disclosed. The transaction instrument can be a smart chip, a RFID tag, credit or debit card or an ATM card and comprises a card body (100); an account identifying mechanism (130) for providing account information associated with the transaction instrument; and an enhanced expiration date generation mechanism (112). A new expiration date is automatically generated at a predetermined interval for a predetermined duration of time, and provided via the enhanced expiration date mechanism. The enhanced expiration date generation mechanism is configured so as to be deactivated if fraudulent activity of the transaction instrument is reported or detected such that new expiration dates are not issued and the transaction instrument is allowed to expire at the end of the next predetermined interval. The transaction instrument can further comprising a security personal identification number (PIN) generation mechanism (110c)where a new security PIN is automatically generated at a predetermined interval and provided via the security PIN generation mechanism. Also disclosed is a system for providing enhanced security to financial transactions using transaction instruments comprising a transaction facilitator service provider central control in communication with a telecommunication network. The transaction facilitator service provider central control includes a processing system, at least one associated database, and an optional Interactive Voice Response (IVR) unit. The at least one associated database comprises account information and expiration date generation information associated with identifiable transaction instruments for verification and authentication of the transaction instruments; and when fraudulent activity relating to a particular transaction instrument is reported or detected, new expiration dates are not issued and the transaction instrument is allowed to expire at the end of the next predetermined interval.
Patent NZ-578053-A (NZ)
Title: Methods of use for cyclopamine analogs
Inventor: TREMBLAY MARTIN
IPC: A01N43/42
Filed: 2007-12-27
Abstract: Disclosed is the use of a cyclopamine compound of formula (1) or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treatment of a hyperproliferative disorder. The compounds are useful in antagonising the hedgehog pathway. The hyperproliferative can be cancer, in particular a cancer of the pulmonary system, a cancer of the gastrointestinal tract, a skin cancer, a genitourinary cancer, a lung cancer, a medulloblastoma, a basal cell carcinoma, a prostate cancer, an esophageal cancer, a hepatocellular cancer, a gastric cancer, a gastrointestinal stromal tumor (GIST), a colon cancer, a colorectal cancer, an ovarian cancer, a melanoma, head and neck cancer, polycythemia Vera, essential thrombocythemia, a soft-tissue sarcoma, fibrosarcoma, myxosarcoma, liposarcoma, a chondrosarcoma, an osteogenic sarcoma, a chordoma, an angiosarcoma, an endotheliosarcoma, a lymphangiosarcoma, a lymphangioendotheliosarcoma, a synovioma, a leiomyosarcoma, a bladder carcinoma, a squamous cell carcinoma, a hepatoma, a bile duct carcinoma, a neuroendocrine cancer, or a carcinoid tumour.
Patent NZ-582877-A (NZ)
Title: Glycosaminoglycan-antagonising mcp-1 mutants and methods of using same
Inventor: KUNGL ANDREAS
IPC: C07K14/52
Filed: 2008-07-31
Abstract: Provided is a MCP-1 mutant protein with increased GAG binding affinity and reduced GPCR activity compared to wild type MCP-1 protein, wherein the MCP-1 protein is modified in a structure-conserving way by replacement of at least two non-basic amino acids by at least two basic and/or electron donating amino acids in the GAG binding region and wherein replacements are at least at amino acid positions 21 and 23. The protein can be used to treat chronic or acute inflammatory diseases or autoimmune conditions.
Patent NZ-589086-A (NZ)
Title: Human serum albumin (HSA) linkers and conjugates thereof
Inventor: MCDONAGH CHARLOTTE
IPC: C12P21/04
Filed: 2009-04-10
Abstract: Provided is an agent comprising a human serum albumin (HSA) linker comprising a specified amino acid sequence with a serine residue at position 34 and a glutamine residue at position 503. The agent can be used as a medicament to treat various cancers, when linked to cytotoxic moieties and targeting binding moieties in therapeutic conjugates.
Patent NZ-589947-A (NZ)
Title: Press mounting device of inner snap ring
Inventor: HU HONGYUAN
IPC: B23P19/02
Filed: 2009-03-13
Abstract: 589947 A mounting device for internal circlips is disclosed. The device comprises a base (1), a cylinder mount (3) and at least two perpendicular sliding guides (2) located between the base board and the cylinder mount. A core rod (9) and a sleeve (12) are movable on the sliding guides with at least two compression springs being located between the core rod (9) and the sleeve (12). A piston rod (8) of the cylinder is fixed on top of the circlip core rod (9) and the sleeve (12) is located coaxial with the circlip core rod (9). The sleeve has an inner conical hole with a big top opening and a smaller bottom opening where the bottom of the circlip core rod (9) can pass through the small bottom opening of the sleeve (12). An orientation board (30) for a work piece (34) to receive the circlip or snap ring is fixed on the base (1) underneath the sleeve (12). In use circlips are positioned at the top of the sleeve and pressed towards the narrow end by the core rod (9) which compresses the circlips for insertion into a receiving groove (34).
Patent NZ-590642-A (NZ)
Title: Magnetic implants for treating obstructive sleep apnea comprising magnetic means for positioning the tongue
Inventor: ROUSSEAU ROBERT A
IPC: A61F5/56
Filed: 2009-07-29
Abstract: An implant for treating sleep disorders comprises a first anchor 25, a first magnet 22 coupled to the first anchor 25, a tongue anchor 36, a second magnet 38 coupled to the tongue anchor 36, and a support 30 for aligning the first and second magnets so that a repelling force is generated between the magnets for urging the second magnet away from the first magnet 22.
Patent NZ-591078-A (NZ)
Title: Protective element for cyclist pants with an intermediate layer positioned between the internal cushions and the surface
Inventor: LAMBERTZ BODO W
IPC: A41D1/084
Filed: 2009-09-03
Abstract: 591078 A protective element for cyclist pants comprising a front protective region 1 and a rear protective region 2 that are connected with each other by means of a tapering 3, where the protective regions 1, 2 and the tapering 3 each have an external threedimensional structure. Cushions 18 are provided within the structure. The cushions include ventilation channels 16. Recesses 8 and/or pockets 9 are formed in the structure. An intermediate layer 17 is positioned between at least one of the cushions and the surface.
Patent NZ-591176-A (NZ)
Title: Pyrrolopyrimidine compounds as cdk inhibitors
Inventor: BESONG GILBERT
IPC: A61K31/519
Filed: 2009-08-20
Abstract: Disclosed herein are compounds of formula I, wherein the variables are defined in the specification, and the use thereof in the treatment of a cancer, such as stomach cancer, breast cancer, pancreatic cancer, colorectal cancer, lung cancer, esophageal cancer, melanoma, squamous cell carcinoma, leukemia, acute lymphocytic leukemia, T cell ALL, neuroblastoma, glioma, a tumor of mesenchymal origin, mantle cell lymphoma and non small cell lung cancer. Examples of compounds of formula I include: 7-cyclopentyl-2-(5-piperazin-1-ylpyridin-2-y lamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide; 4,5,6-tetrahydro-2H-[1,3']bipyridinyl-6'-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethyl amide; and 7-cyclopentyl-2-[4-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-[1 ,2']bipyrazinyl-5'-ylamino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide.
Patent NZ-592400-A (NZ)
Title: Transition metal complexes of bis[thiohydrazide amide] compounds
Inventor: NAGAI MASAZUMI
IPC: C07C327/00
Filed: 2009-10-21
Abstract: Disclosed herein is a compound comprising a bis[thiohydrazide amide] or a deprotonated form thereof complexed to a transition metal cation (preferably Ni2+, Cu2+, Co2+, Fe2+, Zn2+, Pt2+ or Pd2+), wherein the bis[thiohydrazide amide] is represented by the given Structural Formula, compositions comprising said compound and uses thereof. Said compound is useful in the treatment of cancer, particularly melanoma
Patent NZ-593316-A (NZ)
Title: Pyrazine compounds useful as inhibitors of atr kinase
Inventor: CHARRIER JEAN-DAMIEN
IPC: A61K31/4965
Filed: 2009-11-10
Abstract: 593316 The present disclosure relates to pyrazine compounds of formula (Ia) wherein L, n, R1, and R2 are as described in the specification. These compounds are useful as inhibitors of ATR protein kinase. The disclosure also relates to pharmaceutically acceptable compositions comprising the compounds of the disclosure; methods of treating of various diseases, disorders, and conditions using the compounds of the disclosure; processes for preparing the compounds of the disclosure; intermediates for the preparation of the compounds of the disclosure; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. Compounds of the present disclosure include: 2-[5-Amino-6-[5-[4-(methylaminomethyl)phenyl]-1,3,4-oxadiazol-2-yl]pyrazin-2-yl]-N-ethyl-cyclopropanecarboxamide, 1-(4-(5-Amino-6-(5-( 4-((methylamino)methyl)phenyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)piperidin-1-yl)propan-1-one, 1-(7-(5-Amino-6-(5-( 4-CCmethylamino)methy])phenyl)-I,3A-oxadiazol-2-y])pyrazin-2-y])-2,7-diazaspiro[4,4]nonan-2-y])propan-1-one, 1-{ 7-(5-Amino-6-(5-(4-((methylamino)methyllphenyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-2,7-diazaspiro[4,4]nonan-2-yl} propan-1-one, 1-[S-amino-6-(S-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yI]-3 ,6-dihydro-2H-pyridine-4-carboxylic acid, 3-{ [1,2,4(triazolo[1,S-alpyridin-2-y])-S-(1-(ethylsulfony])-1,2,3,6-tetrahydropyridin-4-y])pyrazin-2-amine, 3-amino-N-(pyridin-2-yl)-6-(4-(thiophen-3-ylsulfonyl)piperazin-1-yl)pyrazine-2-carboxamide, 3-amino-6-(4-(phenylcarbonyl)piperazin-1-yl)-N-(pyridin-2-yl)pyrazine-2-carboxamide, 3-(1H-benzo[d]imidazol-2-yl)-5-(1-(thiophen-2-ylsulfonyl)-1,2,3,6-tetrahydropyridin-4-yl)pyrazin-2-amine and 4-(5-amino-6-(3H-imidazo[4,5-b]pyridin-2-yl)pyrazin-2-yl)-N,N-dimethyl-5,6-dihydropyridine-1(2H)-sulfonamide
Patent NZ-595359-A (NZ)
Title: Veterinary topical formulation
Inventor: ALANY RAID
IPC: A01N31/00
Filed: 2011-09-23
Abstract: 595359 Disclosed is a stable formulation suitable for topical administration to cattle including a levamisole active ingredient and at least one active selected from the group known as macrocyclic lactones (for example abamectin, ivermectin, doramectin, eprinomectin, moxidectin and selamectin) with both of said actives being dissolved in a non-aqueous system including one or more solvents selected from the group comprising dimethyl acetamide, dimethyl isosorbide, diethyl phthalate and dimethyl phthalate. Also disclosed is a method for preparing the formulation including: (a) Dissolving at least one of either the levamisole active ingredient or the macrocyclic lactone active ingredient in at least one solvent selected from dimethyl isosorbide, dimethyl acetamide, diethyl phthalate and dimethyl phthalate (b) Adding a co-solvent or co-solvents if desired, and then the second active ingredient if not already dissolved in the solution; or (a) Dissolving at least one of either the levamisole active ingredient or the macrocyclic lactone active ingredient in at least one solvent selected from the chemical groups comprising glyceryl acetates, pyrollidones, glycol ethers, glycol esters, glycerol formal, and alcohols. (b) Adding a co-solvent or co-solvents selected from dimethyl isosorbide, dimethyl acetamide, diethyl phthalate and dimethyl phthalate (c) Adding the second active ingredient if not already dissolved in the solution.
Patent NZ-623779-A (NZ)
Title: Drying rack
Inventor: RICHARD MONTAGUE ADAMS
IPC: D06F58/16
Filed: 2013-04-12
Abstract: A wall mountable electrically operated heated drying rack. The drying rack comprises a frame (200), heating element, electrical connector (400) and may further comprise a mounting bracket(s) (100). The frame is configured to extend over a drying zone and lies in a plane horizontal to the wall. The heating element extends at least partially through the frame. The electrical connector is configured to connect the heating element to a power source and may extend from the frame at position intermediate the width of the drying zone width. The mounting brackets are securable to the frame at a plurality of mounting points and are configured for being securely mountable to a vertical surface. The mounting brackets are mounted to the wall in the horizontal position to promote ease of mounting. The drying rack may be specifically configured for drying towels or the like.
Patent NZ-630401-A (NZ)
Title: Improved reinforcement
Inventor: GARRY JOHN WALKER
IPC: E04G21/12
Filed: 2013-12-17
Abstract: Discloses is a reinforcement for a concrete structure. The reinforcement includes two reinforcing bars (10, 11) spaced apart from each other and secured together by a series of spaced ties. A first end (12a) of each tie being secured to a first (10) of said two reinforcing bars and a second end (12b) of each tie being secured to a second (11) of said two reinforcing bars. Each end of each tie is secured by tightly wrapping said end of the tie around the reinforcing bar for a minimum of 1.5 turns. The reinforcing bars may be in the range of 12-16mm steel. The diameter of the ties may be 6mm, and the ties may be steel. The ties are straight steel bars immediately prior to wrapping around the reinforcing bars.
Patent NZ-631560-A (NZ)
Title: Tile alignment and leveling device
Inventor: KUFNER EDWARD A
IPC: E04F21/22
Filed: 2013-03-29
Abstract: A tile alignment and leveling device for aligning and leveling tiles as they are being secured to a substrate. The device includes a flexible member (10), a bottom plate (12), and an intermediate member (18). The intermediate member (18) spaces the flexible member (10) and bottom plate (12) a predetermined vertical distance. The flexible member (10) has a first end (10a) and a second end (10b). The first end (10a) is pivotally combined with the intermediate member (18) thereby allowing the flexible member (10) to pivot between a first position and a second (downward) position. In use and in its second position, the flexible member’s second end exerts force against the top of the tiles (32) to help align and level the tiles as they are secured to the substrate. The intermediate member can have a portion adjacent to the bottom plate that defines a weakened portion. The intermediate member can be connected to the bottom plate by a shaft which allows the spacing between the plate and intermediate member to be adjusted in use. Preferably the distance can only be reduced such that the tiles (32) are held in place when the flexible members engage the tiles (32). The intermediate member comprises a locking arrangement, such as an opening (16) which can interact with a protrusion of the flexible member, which allows the flexible member (10) to be locked in the second position.
Patent NZ-704092-A (NZ)
Title: Ph adjusted pulse protein product
Inventor: SEGALL KEVIN I
IPC: A23L7/10
Filed: 2013-07-09
Abstract: An aqueous solution of a pulse protein product having a protein content of at least about 60 wt% (N x 6.25) d.b. which is soluble in aqueous media at a pH of less than about 4.4 and heat stable at that pH range is adjusted in pH to a pH of about 6 to about 8. The resulting product is further processed by drying the product, recovering and drying any precipitated pulse protein material, heat treating and then drying the product, or heat treating the product and recovering and drying any precipitated pulse protein material.
Patent NZ-705509-A (NZ)
Title: Vacuum filtration system
Inventor: FREI TIBOR
IPC: A47L9/14
Filed: 2010-09-01
Abstract: Disclosed is a filtration assembly for use with a suction vacuum cleaning device to provide improved air flow to the motor. The filtration assembly includes a housing body for housing one or more filters; and a motor driven impeller which generates suction for drawing air and any entrained material into an inlet through the one or more filters and discharging the air through an outlet. One or more filters includes a first bag filter received by the housing body, the first bag filter including a base portion and a side portion which define a cavity for holding any material that cannot pass through the first bag filter. The side portion of the first bag filter is laterally spaced apart from a wall portion of the housing body such that a gap is formed between the side portion and the wall portion, and the side portion of the first bag filter is composed of a filtering material through which air is able to be drawn; and, wherein suction of the motor generates airflow in the gap by drawing air through the side portion of the first filter bag. The housing body includes an upper portion through which the first bag filter is received and a lower portion, wherein the side portion and base portion of the first bag filter extend down into the lower portion of the housing body wherein the gap between the wall portion of the housing body and the side portion of the first bag filter is greater at the lower portion of the housing body than the upper portion. The side portion and the wall portion diverge towards the lower portion of the housing body, the gap increasing towards the lower portion of the housing body. The housing body cross-section is substantially elliptical in shape.